Associate, AI Buyouts

ABOUT REDESIGN HEALTH: Redesign Health https://www.redesignhealth.com is a global venture and applied technology firm focused on building next-generation healthcare companies. We manage venture capital and venture buyout strategies, each powered by an AI operating system and team of leading technologists, entrepreneurs, and investors. Our venture capital strategy backs exceptional founders at the earliest stage—often before an idea is fully formed—and provides first institutional capital and an unmatched degree of strategic leverage and domain expertise through exit. Our venture buyout strategy partners with proven management teams through control investments and delivers outsized value by rewiring core products and workflows with AI. Since inception in 2018, Redesign and our portfolio companies have touched the lives of more than 15 million patients, raised over $1.5 billion from premier institutional, sovereign, and strategic investors, and built distinctive partnerships with marquee healthcare organizations and senior leaders around the world. Redesign is based in New York and has offices in Bengaluru, Los Angeles, and Riyadh. ROLE SUMMARY: Redesign Health is launching an AI Venture Buyout fund, a next-generation private equity platform that acquires control positions in healthcare companies and uses AI to transform how they operate and grow. Redesign is seeking an Associate, AI Venture Buyouts to play a central role in evaluating and executing healthcare buyout transactions, while supporting post-close AI-driven value creation initiatives. This person will work across the full deal lifecycle—from financial modeling and diligence to market research, deal process management, and portfolio support. WHY THIS ROLE: This is an opportunity to join a new private equity strategy at the ground floor and help shape a next-generation buyout model at the intersection of healthcare, AI, and value creation. Supported by Redesign Health’s capital, ecosystem, and operating infrastructure, the Associate will gain full lifecycle exposure to control investing, operational excellence, and AI-driven value creation. WHAT YOU’LL DO: - Support development of a high-quality deal pipeline and analyze opportunities through review of financials, business models, unit economics, and industry dynamics. - Lead key analytical components of due diligence, develop financial models, and coordinate diligence advisors. - Write investment memos, build financial models, and develop critical market analyses. - Support transaction structuring, documentation review, and closing processes. - Partner with Redesign’s AI and operating teams to support post-close transformation workstreams. - Conduct ongoing competitive and market intelligence to support portfolio companies. - Support preparation of materials for capital raising, LP updates, and internal reviews. IDEAL BACKGROUND: - 2–4 years of experience in private equity, growth equity, investment banking, consulting, and/or corporate development (healthcare experience strongly preferred). - Strong financial modeling capabilities with the ability to build, audit, and interpret detailed operating models. - Experience supporting M&A processes, conducting due diligence, or evaluating services businesses. - Demonstrated interest in healthcare systems, payer–provider dynamics, and regulatory landscapes. - Curiosity and hands-on comfort with AI, automation, and data-driven tools, with interest in applying them to sourcing, diligence, and portfolio work. ADDITIONAL QUALIFICATIONS & COMPETENCIES: - Execution Excellence: Detail-oriented, organized, and rigorous in managing complex workstreams. - Clear Communicator: Able to translate analyses into concise insights for senior leaders, investment committees, and management teams. - Technology Innovator: You have a track record of proactively leveraging AI and other emerging technology tools to create extraordinary productivity and impact within your role. You have built systems